ROARABLE
FREE $100K
Today Screener Big Ideas Track Record 💰 $100K Arena 🎲 Predictions 🏛️ Insiders 8 Analysts
Stock Ratings / Technology / BKYI
ORKT (30) LHSW (31) GYGY (27) IFBD (33) ⌘ Pro Terminal →

BIO-key International Inc. (BKYI) — RQD Stock Rating Cockpit

$2.45 -9.26% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $2.40

BIO-key International Inc. (BKYI) carries a Roarable Rating of D- (Sell) with 35/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D- • RED ALERT Cap $5.5M
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on BKYI Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is BKYI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, BIO-key International Inc. (NASDAQ: BKYI) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 35/100 at a spot price of $2.45 (-9.26% 1D, market cap $5.5M). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 6/20, SEC Balance-Sheet Forensics 10/20, FRED Macro Regime Fit 8/20, and Executive Insider Alignment 7/20. Across 715 tracked Technology issuers, BKYI ranks #526 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does BKYI compare to ORKT and LHSW in the Technology sector?
▼

Within the Technology sector (Computer Software: Prepackaged Software), BKYI carries a Roarable D- (35/100 RQD), trailing P/E of N/A, gross margin of 76.9%, and ROIC of -35.0%. By comparison, ORKT (Orangekloud Technology Inc. (Class A)) holds a E grade (30/100 RQD, P/E N/A, ROIC -35.0%, cap $5.8M) and LHSW (Lianhe Sowell International Group Ltd (Class A)) posts a E grade (31/100 RQD, P/E N/A, ROIC —, cap $5.9M). Among the 5-stock peer group, BKYI leads on earnings multiple (N/A) while BKYI leads on capital efficiency (-35.0% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for BKYI?
▼

Per BKYI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001019034), BIO-key International Inc. generated $5.9M in revenue (-14.3% YoY), $7.2M in net income, and -$4.7M in free cash flow against $8.3M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $2.40 (-1.86%)🧬 Disciplined Float (+0.16% YoY Shares)⚙️ Cash Engine: 4/20 (E) • 0% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record Warning: Scores below 50 (35/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-8.5% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →
RQD QUANT TACHOMETERRED ALERT • D-
025507510035
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D
Cash (4)Whales (6)SEC (10)Macro (8)CEO (7)
Each axis scored 0–20
12M PRICE TARGET CONE-10.2% Base Target
$14 Bull$2 Base$2 Bear
📬 FREE BKYI RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for BKYI)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (35/100 Composite)
🔍 WHY BKYI SCORES 35/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+10/20 pts (29% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 4/9

▲ #2 Bullish Driver: Macro Regime Fit+8/20 pts (23% of score)

FRED Regime × Technicals: 7% of 52W Range • RSI-14 at 50.8 (NEUTRAL RANGE)

▼ #1 Drag / Risk Factor: Cash Engine Quality4/20 pts (-16 pt drag)

Capital intensity & 0% operating margin leave 16 pts on the table

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
43
Grade D$2.83-18.7% Next Q
Q2 (-2Q)
40
Grade D$2.30+19.1% Next Q
Q3 (-1Q)
38
Grade E$2.74-10.6% Next Q
Current
35
Grade D-$2.45-8.5% Hist 90D α
Trajectory: D (43) → D- (35)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a BKYI Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While BKYI currently carries a cautious 35/100 (D-) rating due to Cash Engine Quality (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Technology with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($2.57) and Max Pain ($2.57) forces dealer call-delta covering toward $14.49.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.16% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $BKYI• $4.8M Crowd Pool • Kalshi / Polymarket Composite
Contract: “BKYI Beats Next Quarterly Revenue & EPS Consensus + Hyperscaler AI CapEx Holds Record Pace”
YES 35%NO 65%Trade / Inspect Odds →
RSI-14 MOMENTUMNEUTRAL RANGE
50.830 Oversold · 70 Hot
ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)
3.80>3.0 Fortress Safe
PIOTROSKI F-SCOREWEAK QUALITY (1–4)
4 / 99-Pt Accounting
52-WEEK LASER RANGE7% OF RANGE
L: $2$2.45H: $14
1. Money & Cash Health● WEAK
Are profits real cash in the bank?

Weak cash conversion or heavy valuation strain compared to actual cash earned.

Factor Grade: ERQD 4 / 20
2. Big Money & Insiders● TRIMMING
Are whales & executives buying or selling?

Insiders and big institutional desks have been trimming shares rather than stepping up to buy.

Factor Grade: ERQD 13 / 40
3. Hidden Risks & Market Weather● WARNING
SEC fine-print scan & interest-rate fit

High sensitivity to tight interest rates or new risk warnings added to recent SEC annual filings.

Factor Grade: DRQD 18 / 40
MULTI-MODEL JEV QUANT JURY DELIBERATION

3-of-3 JEV AI Jury Bearish Warning on BKYI

Cash & Moat Bull AI
ROIC & Free Cash Flow Model
BEARISH (20)

-35.0% ROIC with 76.9% gross margin and 2.80% FCF yield.

SEC Forensic Auditor AI
10-K Accruals & Altman-Z Guard
BEARISH (50)

Altman-Z 4.20 and Piotroski 4/9 pass balance-sheet audit.

Whale & Macro Hawk AI
Options Skew, 13F & Fed NetLiq
BEARISH (35)

13/40 institutional & smart-money positioning score with 8/20 macro alignment.

Bull Case: Why Buyers Like BKYI
  • ✓Established market leader in Technology with deep daily trading liquidity.
Bear Case: What Could Go Wrong
  • !Company executives have done more routine share selling than personal cash buying lately.
  • !Sensitive to high interest rates and tighter Federal Reserve market liquidity.
  • !Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring BKYI)

  • ✓Walkthrough of BKYI's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) →$100K Arena
BKYI // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -53.69%▼ DESCENDING CHANNEL
2026-11-03O $2.93H $2.93L $2.45C $2.45VOL 304.8K
RES: $4.05SUP: $0.76SMA50: $2.57SMA200: $4.53
$7.39$5.81$4.23$2.64$1.06RES $4.05SUP $0.76$2.452026-05-042026-06-172026-08-042026-09-182026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

BKYI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 BKYI Butterfly Map → + Track BKYI →
Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
8.0%/yr Implied 5Y Growth

vs. -14.3% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on BKYI today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for BKYI. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for BKYI today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (BKYI)

Technology Rank #526 of 715 ⚔️ ORKT vs BKYI Full Matrix →

1. Head-to-Head Technology Peer Comparison (BKYI vs. ORKT, LHSW, GYGY, IFBD)

Industry: Computer Software: Prepackaged Software (222 Tracked Issuers)

Across 715 tracked Technology securities in the Roarable RQD universe, BIO-key International Inc. (BKYI) ranks #526 by composite RQD confidence (35/100, grade D-) and #669 by equity capitalization ($5.5M). Within this direct 5-issuer industry benchmark cohort, BKYI leads on earnings valuation at N/A trailing P/E, while BKYI leads on capital efficiency and profitability with -35.0% ROIC and 76.9% gross margin. BKYI currently leads its immediate peer cohort in composite quantitative strength at 35/100 (D-).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
BKYI ACTIVE
BIO-key International Inc.
D- 35/100 — 76.9% -35.0% -9.26% $5.5M Benchmark Subject
ORKT
Orangekloud Technology Inc. (Class A)
E 30/100 — 44.2% -35.0% -5.74% $5.8M /orkt-vs-bkyi →
LHSW
Lianhe Sowell International Group Ltd (Class A)
E 31/100 — 21.4% — +0.69% $5.9M /lhsw-vs-bkyi →
GYGY
Game Your Game Inc.
E 27/100 — 8.6% -35.0% -7.12% $6.0M /gygy-vs-bkyi →
IFBD
Infobird Co. Ltd
E 33/100 — 29.5% -35.0% +37.83% $6.1M /ifbd-vs-bkyi →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001019034 ↗

In its most recent audited fiscal period (FY2025, filed 2025-12-31), BIO-key International Inc. (BKYI) reported GAAP revenue of $5.9M (-14.3% vs. FY2024 revenue of $6.9M , and -76.0% cumulative change since FY2023) , GAAP net income of $7.2M, operating cash flow of -$4.7M, and free cash flow of -$4.7M (-59.9% YoY). On the balance sheet, BKYI closed FY2025 with $8.3M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 4/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $5.9M $7.2M -$4.7M -$4.7M $8.3M —
FY2024 (FY) 2024-12-31 $6.9M $4.3M -$2.9M -$2.9M $8.6M $44.8K
FY2023 (FY) 2023-12-31 $24.7M $8.5M -$3.8M -$3.8M — —

3. BKYI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is BKYI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, BIO-key International Inc. (NASDAQ: BKYI) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 35/100 at a spot price of $2.45 (-9.26% 1D, market cap $5.5M). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 6/20, SEC Balance-Sheet Forensics 10/20, FRED Macro Regime Fit 8/20, and Executive Insider Alignment 7/20. Across 715 tracked Technology issuers, BKYI ranks #526 in composite RQD confidence.

How does BKYI compare to ORKT and LHSW in the Technology sector?

Within the Technology sector (Computer Software: Prepackaged Software), BKYI carries a Roarable D- (35/100 RQD), trailing P/E of N/A, gross margin of 76.9%, and ROIC of -35.0%. By comparison, ORKT (Orangekloud Technology Inc. (Class A)) holds a E grade (30/100 RQD, P/E N/A, ROIC -35.0%, cap $5.8M) and LHSW (Lianhe Sowell International Group Ltd (Class A)) posts a E grade (31/100 RQD, P/E N/A, ROIC —, cap $5.9M). Among the 5-stock peer group, BKYI leads on earnings multiple (N/A) while BKYI leads on capital efficiency (-35.0% ROIC).

What are the biggest fundamental strengths and SEC risk factors for BKYI?

Per BKYI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001019034), BIO-key International Inc. generated $5.9M in revenue (-14.3% YoY), $7.2M in net income, and -$4.7M in free cash flow against $8.3M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

Where is BKYI trading relative to its 50-day, 200-day, and 52-week technical levels?

BKYI last traded at $2.45 (-9.26% on volume of 159,111 shares), positioning the stock -4.67% below its 50-day simple moving average ($2.57) and -45.92% below its 200-day simple moving average ($4.53). Across its 52-week range of $1.55 to $13.80, BKYI sits at the 7.3% percentile with a 14-day RSI of 50.8 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($2.14 to $2.76).

Direct Sub-Reports: BKYI RQD Cockpit BKYI 12M Forecast BKYI Earnings & Move BKYI Dividends & DRIP BKYI Insiders & 13F BKYI Whale Options BKYI Profit Sankey BKYI News & Why
ROARABLE RATING BRIEF • RQD 35/100 (D-) ✓ SEC XBRL & RQD VERIFIED

BKYI — BIO-key International Inc.: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

BIO-key International Inc. (BKYI) earns a live Roarable RQD composite score of 35/100, corresponding to a D- letter grade (Roarable Sell) at a spot price of $2.45 (-9.26% 1D, market capitalization $5.5M).

  • Fundamental Cash Engine (4/20): Anchored by return on invested capital (ROIC) of -35.0%, gross margin of 76.9%, operating margin of -60.0%, and free cash flow yield of —.
  • Whale 13F & Options Flow (6/20) + Insider Conviction (7/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (8/20) + Forensic Balance Sheet (10/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of 4/9, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

. Is a NASDAQ-listed issuer in the Technology sector, operating in Computer Software: Prepackaged Software. The profile reports a market capitalization of $0.0B. Customer base and revenue mechanics are — Gross margin is 76.9% per the market data, indicating high gross profitability on sold product, though operating margin is -60%.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), BIO-key International Inc. (BKYI) reported $5.9M in annual revenue (up from $6.9M in FY2024, -14.3% YoY) and $7.2M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($24.7M revenue, $8.5M net income) through FY2025, BKYI scaled operating cash flow to -$4.7M and free cash flow to -$4.7M, backed by $8.3M in total assets against $0 in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • 🐂 Primary Bull Case (D- • RQD 35/100): Established market leader in Technology with deep daily trading liquidity. Free cash flow yield of — and institutional whale pillar of 6/20. With Fundamental Cash Engine at 4/20 and Institutional Whale Flow at 6/20, sustained execution supports upside toward the upper end of the $1.55 – $13.80 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against -60.0% operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Upstream and downstream dependencies are — Sector correlation data beyond the stated beta of 1.0 is — Investors should watch whether new government contract wins translate into revenue lines visible in future filings, since the FY 2025 revenue decline indicates contract momentum has not yet shown up in reported results.

  • Key Question #1: Can BKYI sustain or expand its -60.0% operating margin and -35.0% ROIC against Computer Software: Prepackaged Software peers over the next 4 quarters?
  • Key Question #2: Following FY2025 revenue of $5.9M and free cash flow of -$4.7M, how will capital allocation balance growth reinvestment against $0 in total debt?
  • Key Question #3: How sensitive is BKYI's equity valuation to Technology capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

BKYI Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for BIO-key International Inc. (BKYI) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to BKYI Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

BKYI Bull vs. Bear Conversation Board — What's Your Call at $2.45?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON BKYI 🐻 33% BEARISH CONVICTION
1. Pick Your Side on BKYI:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
MI MidwestValue RQD DEBATE OPENER • Fundamental Long-Only 🐂 BULLISH 🎯 Target: $3.43 (+27.0%)
📌 Pinned Debate

A reported new Middle East government security agency customer and a 76.9% gross margin point to a possible revenue expansion path.

A reported new Middle East government security agency customer and a 76.9% gross margin point to a possible revenue expansion path.. When you look under the hood at BKYI, Fundamental Cash Engine is 4/20 with 76.9% gross margins and -35.0% ROIC. Bears are staring in the rearview mirror while institutional 13F flow (6/20) has been quietly accumulating below $13.80. My 12M target is $3.43.

ArenaChamp_24 🐂 BULL

@MidwestValue Agree on the RQD 35/100 quality, though with 1.0 beta I'm scaling in with half-size at $2.70 and keeping dry powder in case we test $2.51.

FO ForensicBear RQD DEBATE OPENER • 10-K Footnote Auditor 🐻 BEARISH 🎯 Target: $2.24 (-17.0%)
Spot @ $2.70

Operating income and free cash flow are negative in every reported period, with an ROIC of -35% and an RQD score of 38.

Careful chasing BKYI at $2.70. Operating income and free cash flow are negative in every reported period, with an ROIC of -35% and an RQD score of 38.. Gross margin is 76.9%, but operating margin is -60.0%, which shows SG&A and reinvestment are eating into bottom-line EPS. Target $2.24 on multiple compression.

LIVE TAPE SPY $752.10 -1.80% QQQ $681.09 -3.60% DIA $519.34 -1.08% IWM $279.14 -1.68% NVDA $202.06 -1.26% AAPL $338.32 -1.83% MSFT $507.12 -2.83% TSLA $403.82 +1.00% PLTR $178.34 -3.13% SOFI $16.60 -0.95% IBIT $43.35 -5.42% GLD $361.65 -3.59%